BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sousbie M, Vivancos M, Brouillette RL, Besserer-offroy É, Longpré J, Leduc R, Sarret P, Marsault É. Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8–13). J Med Chem 2018;61:7103-15. [DOI: 10.1021/acs.jmedchem.8b00175] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Brouillette RL, Besserer-Offroy É, Mona CE, Chartier M, Lavenus S, Sousbie M, Belleville K, Longpré JM, Marsault É, Grandbois M, Sarret P. Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain. Pharmacol Res 2020;155:104750. [PMID: 32151680 DOI: 10.1016/j.phrs.2020.104750] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Chartier M, Desgagné M, Sousbie M, Côté J, Longpré JM, Marsault E, Sarret P. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic. J Med Chem 2021;64:2110-24. [PMID: 33538583 DOI: 10.1021/acs.jmedchem.0c01726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Todorovic M, Schwab KD, Zeisler J, Zhang C, Bénard F, Perrin DM. Fluorescent Isoindole Crosslink (FlICk) Chemistry: A Rapid, User‐friendly Stapling Reaction. Angew Chem 2019;131:14258-62. [DOI: 10.1002/ange.201906514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Gonzalez S, Dumitrascuta M, Eiselt E, Louis S, Kunze L, Blasiol A, Vivancos M, Previti S, Dewolf E, Martin C, Tourwé D, Cavelier F, Gendron L, Sarret P, Spetea M, Ballet S. Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies. J Med Chem 2020;63:12929-41. [PMID: 32902268 DOI: 10.1021/acs.jmedchem.0c01376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Tétreault P, Besserer-offroy É, Brouillette RL, René A, Murza A, Fanelli R, Kirby K, Parent AJ, Dubuc I, Beaudet N, Côté J, Longpré J, Martinez J, Cavelier F, Sarret P. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog. European Journal of Pharmacology 2020;882:173174. [DOI: 10.1016/j.ejphar.2020.173174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Todorovic M, Schwab KD, Zeisler J, Zhang C, Bénard F, Perrin DM. Fluorescent Isoindole Crosslink (FlICk) Chemistry: A Rapid, User-friendly Stapling Reaction. Angew Chem Int Ed Engl 2019;58:14120-4. [PMID: 31211905 DOI: 10.1002/anie.201906514] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
7 Sarret P. Éric Marsault (1971-2021): A Legacy through the Prism of Relationship Chemistry. J Med Chem 2021;64:5221-4. [PMID: 33760613 DOI: 10.1021/acs.jmedchem.1c00481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vivancos M, Fanelli R, Besserer-Offroy É, Beaulieu S, Chartier M, Resua-Rojas M, Mona CE, Previti S, Rémond E, Longpré JM, Cavelier F, Sarret P. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia. Behav Brain Res 2021;405:113189. [PMID: 33607165 DOI: 10.1016/j.bbr.2021.113189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Herndon JW. The chemistry of the carbon-transition metal double and triple bond: Annual survey covering the year 2018. Coordination Chemistry Reviews 2019;401:213051. [DOI: 10.1016/j.ccr.2019.213051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sun D. Recent Advances in Macrocyclic Drugs and Microwave-Assisted and/or Solid-Supported Synthesis of Macrocycles. Molecules 2022;27:1012. [PMID: 35164274 DOI: 10.3390/molecules27031012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kan Yeung AW, Georgieva MG, Kirilov K, Balacheva AA, Peeva MI, Horbańczuk OK, Horbańczuk JO, Lucarini M, Durazzo A, Santini A, Souto EB, Pajpanova TI, Milella L, Atanasov AG, Tzvetkov NT. Neurotensins and their therapeutic potential: research field study. Future Med Chem 2020;12:1779-803. [PMID: 33032465 DOI: 10.4155/fmc-2020-0124] [Reference Citation Analysis]
12 Chartier M, Desgagné M, Sousbie M, Rumsby C, Chevillard L, Théroux L, Haroune L, Côté J, Longpré JM, Boudreault PL, Marsault É, Sarret P. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog. Biomed Pharmacother 2021;141:111861. [PMID: 34229249 DOI: 10.1016/j.biopha.2021.111861] [Reference Citation Analysis]
13 Iyer MR, Kunos G. Therapeutic approaches targeting the neurotensin receptors. Expert Opin Ther Pat 2021;31:361-86. [PMID: 33393392 DOI: 10.1080/13543776.2021.1866539] [Reference Citation Analysis]
14 Tombling BJ, Lammi C, Lawrence N, Gilding EK, Grazioso G, Craik DJ, Wang CK. Bioactive Cyclization Optimizes the Affinity of a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Peptide Inhibitor. J Med Chem 2021;64:2523-33. [PMID: 33356222 DOI: 10.1021/acs.jmedchem.0c01766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
15 Li D, Minnix M, Allen R, Bading J, Chea J, Wong P, Bowles N, Poku E, Shively JE. Preclinical PET Imaging of NTSR-1-Positive Tumors with 64Cu- and 68Ga-DOTA-Neurotensin Analogs and Therapy with an 225Ac-DOTA-Neurotensin Analog. Cancer Biother Radiopharm 2021;36:651-61. [PMID: 32822229 DOI: 10.1089/cbr.2020.3926] [Reference Citation Analysis]